{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-08-19T12:22:45.366504+00:00",
  "news": [
    {
      "title": "Amgen overturns $50 million damages with ‘inequitable conduct’ defence - IAM Patent",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQWWFMS1V0M0FfTmU1MHQ0amVjb1NoTmJSV1JzNnJVTUd6YW95VldtaEZILThrTVFlcGdoMENQdlNDaFZVeGd4TXN6b2R4SjNCbEVnZTRKdXNXUlZUaHVIU2VLM19HMmFkYnVMNTd5LTV4bjdfeDRBVEZwdnFNdXJFZnFRcFo1TmUtSExXaFN0bGRaQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxQWWFMS1V0M0FfTmU1MHQ0amVjb1NoTmJSV1JzNnJVTUd6YW95VldtaEZILThrTVFlcGdoMENQdlNDaFZVeGd4TXN6b2R4SjNCbEVnZTRKdXNXUlZUaHVIU2VLM19HMmFkYnVMNTd5LTV4bjdfeDRBVEZwdnFNdXJFZnFRcFo1TmUtSExXaFN0bGRaQQ?oc=5\" target=\"_blank\">Amgen overturns $50 million damages with ‘inequitable conduct’ defence</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">IAM Patent</font>",
      "published": "2025-08-19T11:31:47+00:00",
      "source": "IAM Patent"
    },
    {
      "title": "Seven Mile Advisory Acquires Shares of 891 Amgen Inc. (NASDAQ:AMGN) - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPRzBKQmxRQ3Mtc1h3MlAxVFNTaUtWOHZVcmtMWHpPaVhlVGU0bWQzekRUbEFDbm9XR1lPWERZaHNHLXVxUGpRQ0QtZ08zUDVXTWxWaDhTNWk3TFNKSjdOMkN6MVh1RzhHWmRrQkJEWF9FZFhBZkFubzhxUnRBVUk0UVAtZ3J5bUd4MGxNMklmRWE0dFpPS0YyMUdLOXNocDFMcXdOT2hFZE9FeUxBSU41UkU5NFgxaE53ZHNHVVRkVHJsZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPRzBKQmxRQ3Mtc1h3MlAxVFNTaUtWOHZVcmtMWHpPaVhlVGU0bWQzekRUbEFDbm9XR1lPWERZaHNHLXVxUGpRQ0QtZ08zUDVXTWxWaDhTNWk3TFNKSjdOMkN6MVh1RzhHWmRrQkJEWF9FZFhBZkFubzhxUnRBVUk0UVAtZ3J5bUd4MGxNMklmRWE0dFpPS0YyMUdLOXNocDFMcXdOT2hFZE9FeUxBSU41UkU5NFgxaE53ZHNHVVRkVHJsZw?oc=5\" target=\"_blank\">Seven Mile Advisory Acquires Shares of 891 Amgen Inc. (NASDAQ:AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-19T10:54:03+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "US judge overturns Amgen's $50.3 mln loss in cancer drug patent case - Reuters",
      "link": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPMmtjZnZnZXdyRGJKWnpCbDJOWXJMdnhqTlJORXNBTkNFRHpqWk1UYVdleE9OUGpEVWhheUtmUHloVk55OUZ4eVVJUVR1UFhtS2NRT1Z5QnNSTHNLamNuOE9lVHczVnc0a3pjVE5aaThPSmdCb25vMVFFT0ZKWF9iMEtzLTI0cjc0dEVHU1hXMHZZdENWUmpLY2JRM243NXBKWmRlN25lZUYyZGUzX3BjWEkxam8wQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitgFBVV95cUxPMmtjZnZnZXdyRGJKWnpCbDJOWXJMdnhqTlJORXNBTkNFRHpqWk1UYVdleE9OUGpEVWhheUtmUHloVk55OUZ4eVVJUVR1UFhtS2NRT1Z5QnNSTHNLamNuOE9lVHczVnc0a3pjVE5aaThPSmdCb25vMVFFT0ZKWF9iMEtzLTI0cjc0dEVHU1hXMHZZdENWUmpLY2JRM243NXBKWmRlN25lZUYyZGUzX3BjWEkxam8wQQ?oc=5\" target=\"_blank\">US judge overturns Amgen's $50.3 mln loss in cancer drug patent case</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-14T19:28:47+00:00",
      "source": "Reuters"
    },
    {
      "title": "Amgen skirts $50M payout in Blincyto patent litigation tiff with Lindis - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNY1JqYkV1RlVQNVFDZ2tyaFhoXy1qcEtmM1NlZnhoeWVvV2pMUlZ4ZklFbEVJRFVHbC1uZzZoM0RVQmlyOTFJQzdJNV82clo4TDJiNTZWZ0FwSXJpV1k5VmI4anRpc1lMVUJ4Z0Rib09NMDRlaEs3ZFJSNTRBalEwTWExdUtpWF9VZ3ktZlg5SXlOeTM2TGpFSHZGak1VNW8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinwFBVV95cUxNY1JqYkV1RlVQNVFDZ2tyaFhoXy1qcEtmM1NlZnhoeWVvV2pMUlZ4ZklFbEVJRFVHbC1uZzZoM0RVQmlyOTFJQzdJNV82clo4TDJiNTZWZ0FwSXJpV1k5VmI4anRpc1lMVUJ4Z0Rib09NMDRlaEs3ZFJSNTRBalEwTWExdUtpWF9VZ3ktZlg5SXlOeTM2TGpFSHZGak1VNW8?oc=5\" target=\"_blank\">Amgen skirts $50M payout in Blincyto patent litigation tiff with Lindis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-08-15T14:13:20+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOUFNyU2pRekpaUVRXejBINTFheFN1N1VycjdTX1FIaHBmbGxscE5veWNIdWRBZ283UlNidWJFZmhqQVFnNW4zZ1YxMzlWYlpfdDZudjNwQ01WV2x3TlRQcWN1UGd2a180Mm93NW5XUjluMzJfNC00R2xZandhU0Z0SHAzejI?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxOUFNyU2pRekpaUVRXejBINTFheFN1N1VycjdTX1FIaHBmbGxscE5veWNIdWRBZ283UlNidWJFZmhqQVFnNW4zZ1YxMzlWYlpfdDZudjNwQ01WV2x3TlRQcWN1UGd2a180Mm93NW5XUjluMzJfNC00R2xZandhU0Z0SHAzejI?oc=5\" target=\"_blank\">Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-15T14:00:11+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Generative AI Tools Support Amgen’s Mission to Serve Patients - Amgen",
      "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNMmdNbVVGa2tCTHRkdGFsbm9LaFUyOWFpTXhMeGotQTFoOXpuRFBpemY4b0o1aWRrQ1hHUFZua3hWV3FkWUlUUmUyRXZsbTdzRXV1eDlqcjZEbjZkMnV6SHNqM2c2WE1QS2hEYTdsV2RUMWt6OE9GbjUxaEtUMTYzWEF0NjV3S19kOHRrUTdPQWR2ZVZqVk9DRTh0OHFRTm8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinwFBVV95cUxNMmdNbVVGa2tCTHRkdGFsbm9LaFUyOWFpTXhMeGotQTFoOXpuRFBpemY4b0o1aWRrQ1hHUFZua3hWV3FkWUlUUmUyRXZsbTdzRXV1eDlqcjZEbjZkMnV6SHNqM2c2WE1QS2hEYTdsV2RUMWt6OE9GbjUxaEtUMTYzWEF0NjV3S19kOHRrUTdPQWR2ZVZqVk9DRTh0OHFRTm8?oc=5\" target=\"_blank\">Generative AI Tools Support Amgen’s Mission to Serve Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-07-08T07:00:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "Amgen: New Breakthroughs in Obesity, Rare Diseases, & High-Impact Therapies; But Is It Enough? - Smartkarma",
      "link": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPSkwxZkJQOHNxNGYzQ0I3TFFscG9Vb0VZMzdHMkRVSGppZzVwSl83SkJNWUlEQjRkQk1YcHBSek9UZzdpQk1kUG1tNnNtRDF0ZTZrSUV4T3VwOE9XSzF6N3B0Zl9rMjkwclpZOUdoN2ZsX2h3NUppNndUSU0tWmVzbWFmXzRhNExaZl84QTQtN0REeTRGZ3c1M3A3TURIQ0VnVS1OS2E3WXNOQ3F6TzdQTGxpTGhXVkZIamRmLS1lcVE4R2hidFhBdmpWR3drWjY5a3hyRE1qdUg4WUJQbF9KVlYtdVNVUnJQaGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPSkwxZkJQOHNxNGYzQ0I3TFFscG9Vb0VZMzdHMkRVSGppZzVwSl83SkJNWUlEQjRkQk1YcHBSek9UZzdpQk1kUG1tNnNtRDF0ZTZrSUV4T3VwOE9XSzF6N3B0Zl9rMjkwclpZOUdoN2ZsX2h3NUppNndUSU0tWmVzbWFmXzRhNExaZl84QTQtN0REeTRGZ3c1M3A3TURIQ0VnVS1OS2E3WXNOQ3F6TzdQTGxpTGhXVkZIamRmLS1lcVE4R2hidFhBdmpWR3drWjY5a3hyRE1qdUg4WUJQbF9KVlYtdVNVUnJQaGc?oc=5\" target=\"_blank\">Amgen: New Breakthroughs in Obesity, Rare Diseases, & High-Impact Therapies; But Is It Enough?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Smartkarma</font>",
      "published": "2025-08-19T06:08:13+00:00",
      "source": "Smartkarma"
    },
    {
      "title": "Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Round Hill Asset Management - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOakMtdWJadm5Ucm5DWUEyYlJ5ajNJR1Z6ZUtrR21oQXAyS0c5Q0lKc1BmWlhnVlBjME9KTl9EWW9JbE95VVBWWms2dm1PVkJKa3FjbUJ1VHFHT0x3dVRMOXlrSExxOW9YSl80dUQwbnBDOFpfM3FrQ0pMeDJGVHJaejFPZHJELVVMTGc1SXh4ZTQ1b2lwLUhxeGlncXUwbzRBQldBTTIwbXhYWGV6a2o4c3dUdWFEYWppeEdadFJOV3V5RU0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOakMtdWJadm5Ucm5DWUEyYlJ5ajNJR1Z6ZUtrR21oQXAyS0c5Q0lKc1BmWlhnVlBjME9KTl9EWW9JbE95VVBWWms2dm1PVkJKa3FjbUJ1VHFHT0x3dVRMOXlrSExxOW9YSl80dUQwbnBDOFpfM3FrQ0pMeDJGVHJaejFPZHJELVVMTGc1SXh4ZTQ1b2lwLUhxeGlncXUwbzRBQldBTTIwbXhYWGV6a2o4c3dUdWFEYWppeEdadFJOV3V5RU0?oc=5\" target=\"_blank\">Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Round Hill Asset Management</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-19T10:46:25+00:00",
      "source": "MarketBeat"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5\" target=\"_blank\">Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-04-14T07:00:00+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "Q&A: Commercial veteran Susan Sweeney mobilizes decades of drug launch experience at Amgen - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNUnNKcEs1MG1mQ0d4cVBaNDFlS2tNQjY3dTNrRFotS0g1bkNhaFVlaWZPYTVlU0tJMDhjUk9wN2pqXzY3ZFJ4Tk5KX2U1V29vb1ZacE1lbUowazhXNnowdnBKeUZxdkpTM05WczlFblc1S19sZnllR2RfME94RXlPRUJGZnhVaEEyV3pFakJvMFdkYjFUcWN5UEQ0V1dsXzBVVXJ4a3U3a014WGlYYnVnZERB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxNUnNKcEs1MG1mQ0d4cVBaNDFlS2tNQjY3dTNrRFotS0g1bkNhaFVlaWZPYTVlU0tJMDhjUk9wN2pqXzY3ZFJ4Tk5KX2U1V29vb1ZacE1lbUowazhXNnowdnBKeUZxdkpTM05WczlFblc1S19sZnllR2RfME94RXlPRUJGZnhVaEEyV3pFakJvMFdkYjFUcWN5UEQ0V1dsXzBVVXJ4a3U3a014WGlYYnVnZERB?oc=5\" target=\"_blank\">Q&amp;A: Commercial veteran Susan Sweeney mobilizes decades of drug launch experience at Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2025-01-05T08:00:00+00:00",
      "source": "Endpoints News"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-08-18",
      "close": 292.6199951171875
    },
    "history": [
      {
        "date": "2025-08-08",
        "close": 288.2300109863281
      },
      {
        "date": "2025-08-11",
        "close": 285.0899963378906
      },
      {
        "date": "2025-08-12",
        "close": 284.9800109863281
      },
      {
        "date": "2025-08-13",
        "close": 289.3299865722656
      },
      {
        "date": "2025-08-14",
        "close": 290.2900085449219
      },
      {
        "date": "2025-08-15",
        "close": 296.4700012207031
      },
      {
        "date": "2025-08-18",
        "close": 292.6199951171875
      }
    ],
    "name": "Amgen Inc."
  }
}